H, L., AR, F., J, S., K, S., Y, W., G, S., & SK, F. (2024). A generic anti-drug antibody assay for monoclonal antibody therapeutics with broad dynamic range eliminates the need for titer evaluation in preclinical studies. Journal of pharmaceutical and biomedical analysis, 249, 116364. https://doi.org/10.1016/j.jpba.2024.116364
Chicago Style (17th ed.) CitationH, Li, Foley AR, Shim J, Siradze K, Webb-Vargas Y, Sperinde G, and Fischer SK. "A Generic Anti-drug Antibody Assay for Monoclonal Antibody Therapeutics with Broad Dynamic Range Eliminates the Need for Titer Evaluation in Preclinical Studies." Journal of Pharmaceutical and Biomedical Analysis 249 (2024): 116364. https://doi.org/10.1016/j.jpba.2024.116364.
MLA (9th ed.) CitationH, Li, et al. "A Generic Anti-drug Antibody Assay for Monoclonal Antibody Therapeutics with Broad Dynamic Range Eliminates the Need for Titer Evaluation in Preclinical Studies." Journal of Pharmaceutical and Biomedical Analysis, vol. 249, 2024, p. 116364, https://doi.org/10.1016/j.jpba.2024.116364.